Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
Article reviews clinical & methodological heterogeneity of studies of IL-6 antagonists, & considers how this might have influenced reported treatment effects. Severity of illness and concomitant corticosteroids are among factors that might have contributed to inconsistent results
Source:
The Lancet Respiratory Medicine